Pathologicl significance and its inhibition of apoptosis on the development and its progression of liver injury.
Pathologicl significance and its inhibition of apoptosis on the development and its progression of liver injury.
批准号:
10470142
负责人:
KAKUMU Shinichi
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Toxic effects of chloramphenicol, an antibiotic inhibitor of mitochondrial protein synthesis, on rat liver derived RL-34 cell line were completely blocked by a combined treatment with substances endowed with direct or indirect antioxidant properties. A stable, nitroxide free radical scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, and a protein synthesis inhibitor, cycloheximide, suppressed in a similar manner the following manifestations of the chloramphenicol cytotoxicity : (1) Oxidative stress state as evidenced by FACS analysis of cells loaded with carboxy-dichlorodihydrofluorescein diacetate and Mito Tracker CMTH_2MRos ; (2) megamitochondoria formation detected by staining of mitochondria with Mito Tracker CMXRos under a laser confocal microscopy and electron microscopy ; (3) apoptotic changes of the cell detected by the phase contrast microscopy, DNA laddering analysis and cell cycle analysis. Since increases of ROS generation in chloramphenicol-treated cells were the first sign of the chloramphenicol toxicity, we assume that oxidative stress state is a mediator of above described alternations of RL-34 cells including MG formation. Pretreatment of cells with cycloheximide or 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, which is known to be localized into mitochondria, inhibited the megamitochondria formation and succeeding apoptotic changes of the cell. Protective effects of cycloheximide, which enhances the expression of Bcl-2 protein, may further confirm our hypothesis that the megamitochondria formation is a cellular response to an increased ROS generation and raise a possibility that antiapoptotic action of the drug is exerted via the protection of the mitochondria functions.
期刊论文(142)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Wakabayashi T.: "Structural changes of mitochondria related to apoptosis : swelling and megamitochondria formation."Acta Biochim Pol.. 46. 223-237 (1999)
Wakabayashi T.:“与细胞凋亡相关的线粒体结构变化:肿胀和巨线粒体形成。”Acta Biochim Pol.. 46. 223-237 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Karbowski M,Kurono C, et al.: "Free radical-induced megamitochondria formation and apoptosis.Free Radic Biol Med."Free Radic Biol Med.. 26. 396-409 (1999)
Karbowski M、Kurono C 等人:“自由基诱导的巨线粒体形成和凋亡。Free Radic Biol Med.”Free Radic Biol Med.. 26. 396-409 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Karbowski M,Spodnik J, et al.: "Opposite effects of microtuble-stabilizing-and microtuble-destabilizing drugs on biogenesis of mitochondria in mammalian cells."J Cell Sci.. 114. 281-291 (2000)
Karbowski M、Spodnik J 等人:“微管稳定药物和微管去稳定药物对哺乳动物细胞线粒体生物发生的相反作用。”J Cell Sci.. 114. 281-291 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Terazawa-Y;Yoshioka-K;Kobayashi-M;Watanabe-K;Ishigami-M;Yano-M;Takagi-K;Kakumu-S: "Mutations in interferon sensitivity-determining region of hepatitis C virus : its relation to change in viral load."Am-J-Gastroenterol.. 95. 1781-7 (2000)
Terazawa-Y;Yoshioka-K;Kobayashi-M;Watanabe-K;Ishigami-M;Yano-M;Takagi-K;Kakumu-S:“丙型肝炎病毒干扰素敏感性决定区的突变:其与变化的关系
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishigami M,Nishimura H, et al.: "The roles of intrahepatic Va14+NK1.1+T cells for liver injury induced by Salmonella infection in mice.Hepatology."Hepatology. 29. 1799-1808 (1999)
Ishigami M、Nishimura H 等人:“肝内 Va14 NK1.1 T 细胞对小鼠沙门氏菌感染引起的肝损伤的作用。肝病学。”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 70 条
Identification and clinical application for the role of NKT cells in patients with chronic hepatitis and hepatocellualr carcinoma infected hepatitis virus
-
批准号:15390236
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2003
-
负责人:KAKUMU Shinichi
-
依托单位:
To clarify the mechanism of chronicity and to explore therapeutic approach for viral hepatitis
-
批准号:12670529
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:KAKUMU Shinichi
-
依托单位:
IMMUNO-PATHOGENESIS AND-THERAPY OF VIRAL HEPATITIS
-
批准号:09044341
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.24万
-
财政年份:1997
-
负责人:KAKUMU Shinichi
-
依托单位:
Cellular immune response against HBV nucleocapsid antigen
-
批准号:07457593
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.83万
-
财政年份:1995
-
负责人:KAKUMU Shinichi
-
依托单位:
Cellular immune response to core region protein of hepatitis C virus in patients with chronic hepatitis C
-
批准号:05454245
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.58万
-
财政年份:1993
-
负责人:KAKUMU Shinichi
-
依托单位:
Analysis of immunological mechanisms for antibody production to hepatitis B surface antigen.
-
批准号:60570317
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1985
-
负责人:KAKUMU Shinichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: